Human chorionic somato-mammotropin (HCS), proposed
Later, felt the name human chorionic 'growth hormone-prolactin' to be more appropriate as it emphasized not only its lactogenic properties but also its similarity to HGH. More recently it has been agreed that it should be called human chorionic somatomammotrophin HCS , Li et al.
Human chorionic somatomammotropin and its clinical significance. Mar Clin Endocrinol. Saxena Kendall Emerson Herbert A. Human pituitary growth hormone. The primary structure of the hormone. Discover more publications, questions and projects in Placental Hormones. Tissue-specific expression of the human growth hormone gene family. Hormone ontogeny in the ovine fetus. The potential role of beta-endorphin beta-EP as a stimulus to fetal GH, PRL, and chorionic somatomammotropin secretion was investigated in the chronically catheterized ovine fetus.
The peak incremental GH response of Immunoreactivity and receptor binding of mixed recombinants of human growth hormone and chorionic so The behavior in six radioligand assays of the recombinant obtained by the noncovalent complementation of the reduced and carbamoylmethylated residue amino-terminal fragment of human growth hormore with the reduced and carbamoylmethylated residue carboxyl-terminal fragment of human chorionic somatomammotropin was compared to that of the analogous recombinant of the residue The reactions between them discriminated clearly between the homologous and cross-reacting unlabeled hormones.
Arginine infusion tests were carried out on 21 women during the first post-partum week and on 8 healthy nonpregnant women, and the concentration of serum growth hormone, chorionic somatomammotropin HCS , insulin and blood glucose was determined. The mean growth hormone concentration for the post-partum group was significantly less than for controls. Six subjects retested 1—5 months post Synthetic thyrotropin-releasing factor TRF administered iv induced a significant rise within 5 min in the concentration of plasma prolactin and plasma TSH in 13 children with constitutional short stature Group I , 13 patients with isolated growth hormone deficiency Group II , and in 13 patients with idiopathic hypopituitary dwarfism, including TSH deficiency Group III.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable. This publication is from a journal that may support self archiving.